BPC-157
Also known as Body Protection Compound 157
Synthetic pentadecapeptide (gastric juice derived)
One of the most widely studied repair peptides in animal models, examined for tendon, ligament, muscle and gut tissue healing.
How it works
BPC-157 is a synthetic pentadecapeptide derived from a protective protein found in gastric juice, and it is one of the most frequently cited repair peptides in preclinical literature. Its proposed mechanism centers on upregulating VEGF-driven angiogenesis, meaning it promotes new blood vessel growth into damaged tissue, which is a rate-limiting step in most healing processes.
Animal studies also report increased expression of growth hormone receptors in fibroblasts, the cells responsible for laying down collagen. This is thought to accelerate the organization of new collagen fibers and speed the transition from early granulation tissue to a more mature, load-bearing repair.
Beyond musculoskeletal tissue, BPC-157 research extends to gut mucosa, where it is studied for protecting the epithelial lining and supporting recovery from induced ulcers or inflammatory injury in animal models. No large-scale human clinical trials have been published, so its mechanism is inferred primarily from rodent and in vitro work.
What research has shown
Rodent studies show accelerated tendon-to-bone healing, improved muscle crush injury recovery and protection of gut mucosa; no large human trials are published.
Reported ranges in the literature
Low end
200 to 250 mcg daily
Optimal
250 to 500 mcg daily (commonly split AM/PM)
High end
500 to 750 mcg daily in short 4 to 6 week research blocks
Frequency reported in the literature: Daily, typically 4 to 8 week cycles. Note: Often studied locally near the injury site as well as systemically.
Frequently asked questions
What is BPC-157?
BPC-157 is a synthetic pentadecapeptide studied in animal models for tendon, ligament, muscle, and gastrointestinal tissue repair.
How does BPC-157 differ from TB-500?
BPC-157 is primarily studied for angiogenesis and localized tissue repair signaling, while TB-500 is studied for actin-binding cell migration effects across a broader systemic range. They are frequently studied together for complementary pathways.
What does the research show?
Rodent studies report accelerated tendon-to-bone healing, improved recovery from muscle crush injuries, and protective effects on gut mucosa. Human trial data is currently limited.
How is BPC-157 stored?
Lyophilized vials are kept refrigerated or frozen prior to reconstitution. After reconstitution with bacteriostatic water, cold storage and a defined use window are generally recommended based on peptide stability literature.
How long are research blocks typically?
Preclinical protocols commonly use 4 to 8 week research blocks, aligned with the timeline of the tissue repair models being studied.
Related compounds
Further reading
Research use only
All content on this page is general reference information for laboratory research contexts. It is not medical advice, is not intended to direct human use, and does not replace guidance from a licensed healthcare professional. Not for human consumption. Must be 18+.